Windlas Biotech
add_icon

Windlas Biotech

780.15
+16.95
(2.22%)
Market Cap
1,644.34 Cr
PE Ratio
24.12
Volume
65,282.00
Day High - Low
786.00 - 760.00
52W High-Low
1,140.00 - 697.40
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,644.34 Cr
EPS
29.19
PE Ratio
24.12
PB Ratio
3.01
Book Value
253.05
EBITDA
112.10
Dividend Yield
0.76 %
Industry
Healthcare
Return on Equity
12.06
Debt to Equity
0.04
Forecast For
Actual

Company News

View All News
Caret
positive
Windlas Biotech Limited shareholders approved the re-appointment of three directors through postal ballot with overwhelming support, including Whole-time Director Ashok Kumar Windlass and Independent Directors Vivek Dhariwal and Gaurav Gulati.
positive
Windlas Biotech Limited allotted 28,990 equity shares on March 13, 2026, under two employee stock option plans, with majority allocation from WBL ESOP Scheme 2023.
negative
Windlas Biotech receives show cause notice from Uttarakhand FDA for temporary suspension of codeine-containing cough syrup manufacturing. Affected product line contributed Rs. 55.21 crore to revenue.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,795.40
#1 4,30,776.60
38.40
#1 54,729.00
9.71
#1 10,980
16.07
56.77
6,014.50
1,59,666.08
64.50
9,712.00
18.67
2,191
-1.02
40.37
4,297.50
1,45,446.93
63.41
11,539.40
6.99
1,911
26.24
52.50
1,300.70
1,08,560.37
19.04
33,741.20
16.73
5,725
-15.28
53.74
2,347.60
1,07,238.09
22.82
22,909.50
13.74
3,306
#1 37.44
59.20
1,244.40
1,00,519.12
21.73
28,409.50
7.12
5,291
-57.18
35.20
903.70
90,933.37
#1 17.75
23,511.00
18.55
4,615
-0.32
51.17
2,024.00
83,551.75
45.50
12,744.20
#1 20.90
2,007
7.65
43.19
1,307.80
75,957.24
21.35
32,345.60
9.43
3,484
7.59
62.57
5,435.50
64,989.56
26.15
13,458.30
3.70
2,216
1.90
49.75
Growth Rate
Revenue Growth
20.72 %
Net Income Growth
4.81 %
Cash Flow Change
-37.42 %
ROE
-6.73 %
ROCE
-4.30 %
EBITDA Margin (Avg.)
1.34 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
75
109
102
118
108
112
117
119
125
123
135
122
143
147
156
165
176
179
192
199
208
215
226
238
Expenses
70
116
89
100
96
99
102
105
108
106
117
106
124
128
134
142
149
154
164
170
177
184
194
209
EBITDA
5
-7
13
18
12
13
14
15
17
17
19
16
19
20
22
24
26
25
28
29
31
32
32
29
Operating Profit %
6 %
-13 %
12 %
15 %
10 %
11 %
11 %
11 %
11 %
12 %
12 %
12 %
12 %
12 %
12 %
13 %
13 %
12 %
12 %
13 %
13 %
13 %
13 %
10 %
Depreciation
3
3
3
3
3
3
3
3
3
3
3
3
4
3
3
3
4
6
7
7
8
7
8
8
Interest
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
1
2
1
1
1
1
Profit Before Tax
2
-11
9
15
8
10
11
12
14
14
16
13
15
16
18
20
23
18
20
20
21
23
24
20
Tax
1
2
-0
2
2
3
3
3
-1
4
4
4
4
4
4
5
6
5
5
5
5
6
6
5
Net Profit
1
-12
9
12
6
7
8
8
15
10
12
9
11
12
14
15
17
14
16
16
16
18
18
15
EPS in ₹
0.36
-6.47
5.18
6.75
3.24
3.67
4.11
3.81
6.97
4.50
5.59
4.23
5.37
5.79
6.75
7.26
8.17
6.47
7.49
7.45
7.77
8.43
8.48
7.12

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
290
298
339
296
491
529
626
761
Fixed Assets
87
64
70
96
91
109
179
223
Current Assets
144
121
168
194
382
354
431
525
Capital Work in Progress
53
5
0
0
8
15
6
5
Investments
23
122
116
23
65
107
173
223
Other Assets
128
107
152
177
327
298
268
308
Total Equity & Liabilities
290
298
339
296
491
529
626
761
Current Liabilities
143
96
125
93
94
121
172
249
Non Current Liabilities
22
8
4
4
2
6
5
5
Total Equity
125
194
210
199
395
402
450
506
Reserve & Surplus
117
187
203
193
384
392
440
495
Share Capital
6
6
6
6
11
11
10
11

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-2
6
5
-8
-15
3
2
-5
Investing Activities
-11
-7
-14
-20
-155
-14
-92
-74
Operating Activities
35
19
25
12
9
61
109
68
Financing Activities
-26
-6
-5
1
130
-44
-15
1

Share Holding

% Holding
May 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Feb 2023
Mar 2023
Apr 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
78.00 %
59.95 %
59.95 %
59.95 %
59.95 %
59.95 %
59.95 %
60.75 %
61.22 %
62.44 %
62.44 %
62.82 %
62.82 %
62.82 %
62.82 %
62.51 %
62.51 %
62.51 %
62.34 %
62.34 %
61.99 %
61.99 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.35 %
1.18 %
1.59 %
2.00 %
1.55 %
1.52 %
1.44 %
1.11 %
0.93 %
DIIs
0.00 %
9.81 %
9.43 %
10.02 %
9.62 %
12.02 %
11.14 %
12.21 %
12.27 %
11.64 %
11.64 %
11.53 %
10.47 %
11.71 %
11.82 %
10.35 %
9.58 %
10.26 %
10.89 %
11.21 %
11.43 %
11.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
17.11 %
20.52 %
22.20 %
23.61 %
21.57 %
22.98 %
22.70 %
22.18 %
22.00 %
22.00 %
22.02 %
21.63 %
21.21 %
21.19 %
21.76 %
21.80 %
21.54 %
21.36 %
20.87 %
21.30 %
21.29 %
Others
22.00 %
13.13 %
10.10 %
7.83 %
6.82 %
6.47 %
5.92 %
4.34 %
4.33 %
3.92 %
3.92 %
3.63 %
5.07 %
2.90 %
3.00 %
3.79 %
4.11 %
4.14 %
3.89 %
4.14 %
4.17 %
4.35 %
No of Share Holders
8
1,04,227
1,08,818
99,271
92,115
88,746
86,801
82,690
80,912
78,829
78,829
75,470
68,798
61,900
51,277
45,824
45,706
46,590
46,383
45,887
45,433
45,461

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 3.5 4 5.5 5.8 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 1.56 0.78 0.53 0.76 0.00

Announcements

Closure of Trading Window1 day ago
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot6 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report6 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Sub: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 10, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference CallFeb 06, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 05, 2026
Announcement under Regulation 30 (LODR)-CessationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Unaudited Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Board Meeting Outcome for Approval Of Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Thursday February 5 2026Jan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 29, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 11, 2025
Recording Of Conference CallNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Board Meeting Outcome for Unaudited Financial Results For H1 Of FY26Nov 06, 2025
Outcome Of The Board Meeting Held On November 6 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 29, 2025
Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025.Oct 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 03, 2025
Closure of Trading WindowSep 29, 2025
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Grant Of Stock Options/ Units Under Windlas Plan 2025 (Plan)Sep 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 06, 2025
Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Sep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Outcome Of Nomination And Remuneration Committee MeetingAug 24, 2025
Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - Amendments To Sub-Clause 3.2 Of The Windlas Plan 2025 (Plan)Aug 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference CallAug 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025

Mutual Fund Holdings

Technical Indicators

RSI(14)
Neutral
53.06
ATR(14)
Volatile
29.60
STOCH(9,6)
Neutral
48.13
STOCH RSI(14)
Overbought
94.47
MACD(12,26)
Bullish
3.34
ADX(14)
Weak Trend
14.17
UO(9)
Bearish
56.14
ROC(12)
Uptrend And Accelerating
2.67
WillR(14)
Overbought
-15.21